246 Chapter 8 39. Kermorgant S, Parker PJ. c-Met signalling: spatio-temporal decisions. Cell Cycle 2005;4:352-5. 40. Vogt PK. Jun, the oncoprotein. Oncogene 2001;20:2365-77. 41. Barrow-McGee R, Kermorgant S. Met endosomal signalling: in the right place, at the right time. Int J Biochem Cell Biol 2014;49:69-74. 42. Kermorgant S, Parker PJ. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J Cell Biol 2008;182:855-63. 43. Yin F, Cadenas E. Mitochondria: the cellular hub of the dynamic coordinated network. Antioxid Redox Signal 2015;22:961-4. 44. Khacho M, Slack RS. Mitochondrial dynamics in the regulation of neurogenesis: From development to the adult brain. Dev Dyn 2018;247:47-53. 45. Rambold AS, Pearce EL. Mitochondrial Dynamics at the Interface of Immune Cell Metabolism and Function. Trends Immunol 2018;39:6-18. 46. Chan DC. Mitochondrial Dynamics and Its Involvement in Disease. Annu Rev Pathol 2020;15:235-59. 47. Mozdy AD, McCaffery JM, Shaw JM. Dnm1p GTPase-mediated mitochondrial fission is a multi-step process requiring the novel integral membrane component Fis1p. J Cell Biol 2000;151:367-80. 48. Smirnova E, Shurland DL, Ryazantsev SN, van der Bliek AM. A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol 1998;143:351-8. 49. Karimi D, Pedram N, Kakaei F, Asadi M, Poursaei E, Kermani TA. FIS1 Overexpression Is Correlated with Tumor Metastasis in Gastric Adenocarcinoma. J Gastrointest Cancer 2022;53:466-71. 50. Shi L, Liu J, Peng Y, Zhang J, Dai X, Zhang S, et al. Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission. Mol Oncol 2020;14:3169-83. 51. Jo Y, Cho HM, Sun W, Ryu JR. Localization of dynamin-related protein 1 and its potential role in lamellipodia formation. Histochem Cell Biol 2017;148:13-20. 52. Trotta AP, Chipuk JE. Mitochondrial dynamics as regulators of cancer biology. Cell Mol Life Sci 2017;74:1999-2017. 53. Yu Y, Peng XD, Qian XJ, Zhang KM, Huang X, Chen YH, et al. Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis. Signal Transduct Target Ther 2021;6:401. 54. Godinho MF, Wulfkuhle JD, Look MP, Sieuwerts AM, Sleijfer S, Foekens JA, et al. BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib. Br J Cancer 2012;107:947-55. 55. Jensen EV, Jordan VC. The estrogen receptor: a model for molecular medicine. Clin Cancer Res 2003;9:1980-9. 56. Musgrove EA, Sutherland RL. Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 2009;9:631-43. 57. Massarweh S, Schiff R. Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities. Clin Cancer Res 2007;13:1950-4. 58. Riggins RB, Schrecengost RS, Guerrero MS, Bouton AH. Pathways to tamoxifen resistance. Cancer Lett 2007;256:1-24. 59. Godinho M, Meijer D, Setyono-Han B, Dorssers LC, van Agthoven T. Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells. J Cell Physiol 2011;226:1741-9. 60. Meijer D, van Agthoven T, Bosma PT, Nooter K, Dorssers LC. Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells. Mol Cancer Res 2006;4:379-86. 61. van Agthoven T, Godinho MF, Wulfkuhle JD, Petricoin EF, 3rd, Dorssers LC. Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines. Int J Cancer 2012;131:1998-2007.
RkJQdWJsaXNoZXIy MTk4NDMw